These are tips and suggestions for lowering your risk of infection due to HCM.

Hypertrophic cardiomyopathy treatment: What to expect, types of medications, surgeries and procedures, lifestyle changes, and more.

Capricor Therapeutics has completed its US marketing application for deramiocel, a cell therapy the US biotech hopes will become the first approved treatment for cardiomyopathy associated with ...

KUTV — Feline Hypertrophic Cardiomyopathy (HCM) is the most common heart disease in cats, affecting felines of all breeds and ages. This condition causes the walls of the heart’s left ...

Hypertensive disorders of pregnancy (HDP) in first pregnancies significantly increased the risk for dilated cardiomyopathy (DCM), with an early onset of 5.1 years postpartum compared with 10.6 ...

The European Commission has approved BridgeBio's acoramidis for life-threatening heart disorder transthyretin amyloidosis cardiomyopathy (ATTR-CM), setting up a market clash with Pfizer.

Hypertrophic Cardiomyopathy Program, Division of Cardiology, Toronto General Hospital; Department of Medicine, University of Toronto,Toronto, ON Anthony Ralph-Edwards, MD, FRCSC, Division of ...

Septal myectomy is a type of open-heart surgery for thick heart muscle (hypertrophic cardiomyopathy). It decreases symptoms of the condition. A muscular wall called the septum separates the left and ...

Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited cardiomyopathy characterised by fibrofatty replacement of predominantly the right ventricle and high risk of ventricular ...

Cardiomyopathies are diseases of the heart muscle. This group of pathological conditions includes dilated cardiomyopathy, hypertrophic cardiomyopathy, restrictive cardiomyopathy, arrhythmogenic ...

You will be able to get a quick price and instant permission to reuse the content in many different ways. The differentiation of restrictive cardiomyopathy and constrictive pericarditis has been a ...

Reason for decision Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in ...